Medicare Enrolled
Dr. David Waterhouse, MD
Hematology & Oncology · Cincinnati, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Waterhouse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waterhouse?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Waterhouse
Dr. David Waterhouse is a hematology & oncology specialist in Cincinnati, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Waterhouse performed 1,146 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Waterhouse received a total of $1,054,656 from 45 pharmaceutical and/or device companies across 976 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Waterhouse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 29% volume in OH
$1,054,656 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,146
Medicare services
Top 29% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
374 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
149 | $81 | $348 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
116 | $8 | $35 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
90 | $93 | $343 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
70 | $10 | $62 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $54 | $230 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
54 | $94 | $673 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
39 | $21 | $152 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $63 | $268 |
| New patient office visit, complex (60-74 min) | 26 | $152 | $644 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $118 | $540 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $139 | $732 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
21 | $11 | $105 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
19 | $47 | $304 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.8% high complexity
38.4% medium
51.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,054,656
Total received (2018-2024)
Avg $150,665/year across 7 years
Top 1% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
976
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$205,537
2023
$259,387
2022
$210,495
2021
$153,208
2020
$103,842
2019
$82,404
2018
$39,782
Payments by company (2024)
Janssen Biotech, Inc.
$70,627
Amgen Inc.
$56,179
Merck Sharp & Dohme LLC
$30,160
E.R. Squibb & Sons, L.L.C.
$24,941
AstraZeneca Pharmaceuticals LP
$11,225
Janssen Scientific Affairs, LLC
$2,477
ABBVIE INC.
$2,469
PFIZER INC.
$1,588
Aveo Pharmaceuticals, Inc.
$1,480
Bayer Healthcare Pharmaceuticals Inc.
$1,428
Daiichi Sankyo Inc.
$1,311
Ethicon Inc.
$938
Astellas Pharma US Inc
$136
BIOPROTECT MEDICAL, INC.
$117
JAZZ PHARMACEUTICALS INC.
$66
Cumberland Pharmaceuticals, Inc.
$64
PROGENICS PHARMACEUTICALS, INC.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$50
Novartis Pharmaceuticals Corporation
$46
Lilly USA, LLC
$36
Fresenius Kabi USA, LLC
$34
Gilead Sciences, Inc.
$24
Incyte Corporation
$22
Stemline Therapeutics Inc.
$17
GENZYME CORPORATION
$14
Regeneron Healthcare Solutions, Inc.
$14
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 76.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$346,015
E.R. Squibb & Sons, L.L.C.
$199,452
Amgen Inc.
$182,315
AstraZeneca Pharmaceuticals LP
$93,956
Merck Sharp & Dohme LLC
$45,858
EMD Serono, Inc.
$44,633
GENZYME CORPORATION
$26,098
PFIZER INC.
$23,172
Fresenius Kabi USA, LLC
$17,221
JAZZ PHARMACEUTICALS INC.
$11,131
Janssen Scientific Affairs, LLC
$10,771
Merck Sharp & Dohme Corporation
$10,456
Lilly USA, LLC
$6,786
Seattle Genetics, Inc.
$5,125
Novartis Pharmaceuticals Corporation
$4,019
Seagen Inc.
$3,255
Eisai Inc.
$2,970
ABBVIE INC.
$2,469
Exelixis Inc.
$2,450
Takeda Pharmaceuticals U.S.A., Inc.
$2,345
Regeneron Healthcare Solutions, Inc.
$2,306
Celgene Corporation
$1,938
Jazz Pharmaceuticals Inc.
$1,662
Bayer Healthcare Pharmaceuticals Inc.
$1,575
Aveo Pharmaceuticals, Inc.
$1,480
Gilead Sciences, Inc.
$1,356
Daiichi Sankyo Inc.
$1,311
Ethicon Inc.
$938
NOVARTIS PHARMACEUTICALS CORPORATION
$675
Astellas Pharma US Inc
$154
Genentech USA, Inc.
$150
BIOPROTECT MEDICAL, INC.
$117
Myovant Sciences Inc.
$95
Kite Pharma, Inc.
$88
Cumberland Pharmaceuticals, Inc.
$64
PROGENICS PHARMACEUTICALS, INC.
$63
Incyte Corporation
$35
Bayer HealthCare Pharmaceuticals Inc.
$34
G1 Therapeutics, Inc.
$29
Dendreon Pharmaceuticals LLC
$20
Stemline Therapeutics Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$14
Sumitomo Pharma America, Inc.
$14
Blue Earth Diagnostics Limited
$13
Epizyme, Inc.,
$12
Top 3 companies account for 69.0% of all-time payments
Associated products mentioned in payments ›
Alecensa · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · Bavencio · COSELA · Cabometyx · DARZALEX · ELIQUIS · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FOTIVDA · FRUZAQLA · IBRANCE · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kabiven · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · Monarch Platform · Neulasta · Nubeqa · OPDIVO · ORGOVYX · Orserdu · PADCEV · PLUVICTO · PROVENGE · PYLARIFY · Padcev · REBLOZYL · RYBREVANT · SANCUSO · SCEMBLIX · Sodium Chloride · Stimufend · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tepmetko · Tepotinib · Trodelvy · VENCLEXTA · VERZENIO · Vitrakvi · Vyloy · XTANDI · Xofigo · Xtandi · Yescarta · ZEPZELCA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
69
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
MERCY HEALTH - WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Waterhouse is a clinical cardiology specialist, with above-average Medicare volume (top 29% in OH), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Waterhouse experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Waterhouse performed 374 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Waterhouse receive payments from pharmaceutical companies?
Yes. Dr. Waterhouse received a total of $1,054,656 from 45 companies across 976 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waterhouse's costs compare to other hematology & oncology specialists in Cincinnati?
Dr. Waterhouse's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waterhouse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Cincinnati
Browse hematology & oncology specialists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology